Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

Table 8A.Proposed FY 2024 Statewide Average Operating Cost-to-Charge Ratios (CCRs) for Acute Care Hospitals (Urban and Rural) Table 8B.Proposed FY 2024 Statewide Average Capital Cost-to-Charge Ratios (CCRs) for Acute Care Hospitals Table 10.Codes Provided by FY 2024 New Technology Add-On Payment Applicants for Their Cost Analyses Table 16.Proxy Hospital Value-Based Purchasing (VBP) Program Adjustment Factors for FY 2024 Table 18.Proposed FY 2024 Medicare DSH Uncompensated Care Payment Factor 3 The following LTCH PPS tables for this FY 2024 final rule are available through the internet on the CMS website at under the list item for Regulation Number CMS-1785-P: Table 8C.Proposed FY 2024 Statewide Average Total Cost-to-Charge Ratios (CCRs) for LTCHs (Urban and Rural) Table 11.Proposed MS-LTC-DRGs, Relative Weights, Geometric Average Length of Stay, and Short-Stay Outlier (SSO) Threshold for LTCH PPS Discharges Occurring From October 1, 2023, Through September 30, 2024 Table 12A.Proposed LTCH PPS Wage Index for Urban Areas for Discharges Occurring From October 1, 2023, Through September 30, 2024 Table 12B.Proposed LTCH PPS Wage Index for Rural Areas for Discharges Occurring From October 1, 2023, Through September 30, 2024 ( Appendix A: Economic Analyses I

2024;38:e23592
Positive Feedback From the Post-Trial Questionnaire: 96.77% reported visibly brighter skin 93.55% felt their skin looked more radiant and healthier 90.32% noticed their skin looked younger and more hydrated 80.65% saw a more even skin tone 74.19% agreed that dark spots had faded and their complexion was clearer 70.97% saw improvements in signs of ageing What Makes Altrient Liposomal Glutathione Stand Out From the Crowd
Bioavailability study of an innovative Orobuccal formulation of glutathione